Regeneron Pharmaceuticals Inc. revenue breakdown overview

Regeneron Pharmaceuticals Inc. revenue for the last year amounted to 11.88 B EUR, the most of which — 11.88 B EUR — came from its highest performing source at the moment, Medicines, the year earlier bringing 11.37 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Regeneron Pharmaceuticals Inc. 6.12 B EUR, and the year before that — 6.37 B EUR.